The Pharmalot blog reports today on a Reuter's story about an oral vaccine for Alzheimer's that proved successful at diminishing signs of Alzheimer's in a study of 28 mice bred to develop the disease. Limited testing of the vaccine in humans may be next.
The vaccine works by reducing the amount of amyloid plaques in the brains of the diseased mice, visibly improving their cognitive function. "In other words," writes Ed Silverman at Pharmalot, "[the mice] could find their way to the kitchen counter again."
More like this
As Obama solidifies his teams on science, education, and environment, attention -- and not a little worry from the drug industry -- is turning toward his hunt for a new FDA commissioner.
Following up on the wacky tobaccy post, the FDA advisory panel voted 14-0 against recommendation of rimonabant to move forward as a treatment for obesity, citing the need for further safety studies. As noted, the primary concerns are psychiatric/neurological issues.
What's new at the FDA?
The Pump Handle's Liz Borowski put up a nice post summarizing the key points of the >400-page Food and Drug Administration Amendments Act of 2007 (